Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Aura Burian"'
Autor:
Jeffrey R. Whiteaker, Rachel A. Lundeen, Lei Zhao, Regine M. Schoenherr, Aura Burian, Dongqing Huang, Ulianna Voytovich, Tao Wang, Jacob J. Kennedy, Richard G. Ivey, Chenwei Lin, Oscar D. Murillo, Travis D. Lorentzen, Mathangi Thiagarajan, Simona Colantonio, Tessa W. Caceres, Rhonda R. Roberts, Joseph G. Knotts, Joshua J. Reading, Jan A. Kaczmarczyk, Christopher W. Richardson, Sandra S. Garcia-Buntley, William Bocik, Stephen M. Hewitt, Karen E. Murray, Nhan Do, Mary Brophy, Stephen W. Wilz, Hongbo Yu, Samuel Ajjarapu, Emily Boja, Tara Hiltke, Henry Rodriguez, Amanda G. Paulovich
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor
Externí odkaz:
https://doaj.org/article/2231b7f4bf4c4dfdac9a7d21bf8f78b2
Autor:
Aura Burian, Kevin L Wang, Kathryn A K Finton, Ni Lee, Akiko Ishitani, Roland K Strong, Daniel E Geraghty
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163297 (2016)
Based on previous findings supporting HLA-F as a ligand for KIR3DL2 and KIR2DS4, we investigated the potential for MHC-I open conformers (OCs) as ligands for KIR3DS1 and KIR3DL1 through interactions measured by surface plasmon resonance. These measur
Externí odkaz:
https://doaj.org/article/df2e1b586dc349829aeba6c0b847e6fb
Autor:
Jacob J. Kennedy, Jeffrey R. Whiteaker, Richard G. Ivey, Aura Burian, Shrabanti Chowdhury, Chia-Feng Tsai, Tao Liu, ChenWei Lin, Oscar D. Murillo, Rachel A. Lundeen, Lisa A. Jones, Philip R. Gafken, Gary Longton, Karin D. Rodland, Steven J. Skates, John Landua, Pei Wang, Michael T. Lewis, Amanda G. Paulovich
Publikováno v:
Analytical Chemistry. 94:9540-9547
Despite advances in proteomic technologies, clinical translation of plasma biomarkers remains low, partly due to a major bottleneck between the discovery of candidate biomarkers and costly clinical validation studies. Due to a dearth of multiplexable
Autor:
Oscar Murillo, Tao Liu, Rachel A. Lundeen, Richard G. Ivey, Chenwei Lin, Aura Burian, Amanda G. Paulovich, Pei Wang, John D. Landua, Shrabanti Chowdhury, Philip R. Gafken, Michael T. Lewis, Chia-Feng Tsai, Gary Longton, Jacob J. Kennedy, Steven J. Skates, Jeffrey R. Whiteaker, Karin D. Rodland, Lisa A. Jones
Despite advances in proteomic technologies, clinical translation of plasma biomarkers remains low, partly due to a major bottleneck between the discovery of candidate biomarkers and downstream costly clinical validation studies. Due to a dearth of mu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8cae76699093a357b6bd1cea8e5859fa
https://doi.org/10.1101/2021.09.02.458791
https://doi.org/10.1101/2021.09.02.458791
Autor:
Rhonda R. Roberts, Christopher W. Richardson, Aura Burian, Lei Zhao, Karen E. Murray, Regine M. Schoenherr, Amanda G. Paulovich, Sandra S. Garcia-Buntley, Jan Kaczmarczyk, Oscar Murillo, Mathangi Thiagarajan, Richard G. Ivey, Emily S. Boja, Rachel A. Lundeen, Samuel Ajjarapu, Ulianna Voytovich, Hongbo Yu, Chenwei Lin, Tessa W. Caceres, Jacob J. Kennedy, William Bocik, Tara Hiltke, Joshua J. Reading, Henry Rodriguez, Stephen M. Hewitt, Nhan Do, Stephen W. Wilz, Dongqing Huang, Simona Colantonio, Mary Brophy, Jeffrey R. Whiteaker, Joseph G. Knotts, Travis D. Lorentzen, Tao Wang
Publikováno v:
Frontiers in Immunology
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology, Vol 12 (2021)
Immunotherapies are revolutionizing cancer care, producing durable responses and potentially cures in a subset of patients. However, response rates are low for most tumors, grade 3/4 toxicities are not uncommon, and our current understanding of tumor
Publikováno v:
The Journal of Immunology. 191:3553-3562
Killer Ig-like receptors (KIRs) are innate immune receptors expressed by NK and T cells classically associated with the detection of missing self through loss of their respective MHC ligand. Some KIR specificities for allelic classical class I MHC (M
Autor:
Kevin L. Wang, Daniel E. Geraghty, Ni Lee, Kathryn A. K. Finton, Roland K. Strong, Aura Burian, Akiko Ishitani
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163297 (2016)
PLoS ONE
PLoS ONE
Based on previous findings supporting HLA-F as a ligand for KIR3DL2 and KIR2DS4, we investigated the potential for MHC-I open conformers (OCs) as ligands for KIR3DS1 and KIR3DL1 through interactions measured by surface plasmon resonance. These measur
Publikováno v:
The Journal of Immunology. 184:6199-6208
HLA-F has low levels of polymorphism in humans and is highly conserved among primates, suggesting a conserved function in the immune response. In this study, we probed the structure of HLA-F on the surface of B lymphoblastoid cell lines and activated
Publikováno v:
Journal of Biological Chemistry. 278:14469-14479
Phox (PX) domains are phosphoinositide (PI)-binding domains with broad PI specificity. Two cytosolic components of NADPH oxidase, p40phox and p47phox, contain PX domains. The PX domain of p40phox specifically binds phosphatidylinositol 3-phosphate, w
Autor:
Daniel Geraghty, Kevin L Wang, Ni Lee, Aura Burian, Jodie P Goodridge, Akiko Ishitani, John McNevin, Margaret J McElrath
Publikováno v:
The Journal of Immunology. 198:146.13-146.13
HLA-F is expressed as a protein independent of bound peptide or β2-microglobulin and surface expression is upregulated upon activation in dendritic cells, monocytes and most lymphocyte subsets. MHC class I (MHCI) is also expressed on proliferating l